BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16424656)

  • 1. Diastolic dysfunction and pulmonary hypertension in sickle cell anemia: is there a role for L-carnitine treatment?
    El-Beshlawy A; Abd El Raouf E; Mostafa F; Talaat M; Isma'eel H; Aoun E; Hoffbrand AV; Taher A
    Acta Haematol; 2006; 115(1-2):91-6. PubMed ID: 16424656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
    El-Beshlawy A; Youssry I; El-Saidi S; El Accaoui R; Mansi Y; Makhlouf A; Taher A
    Pediatr Hematol Oncol; 2008 Dec; 25(8):734-43. PubMed ID: 19065439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current issues in blood transfusion for sickle cell disease.
    Wahl S; Quirolo KC
    Curr Opin Pediatr; 2009 Feb; 21(1):15-21. PubMed ID: 19242238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in sickle cell disease.
    Vichinsky EP
    N Engl J Med; 2004 Feb; 350(9):857-9. PubMed ID: 14985481
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary hypertension in children with sickle cell disease.
    Zuckerman WA; Rosenzweig EB
    Expert Rev Respir Med; 2011 Apr; 5(2):233-43. PubMed ID: 21510733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic abnormalities in adolescent and adult Saudi patients with sickle cell disease.
    Aleem A; Jehangir A; Owais M; Al-Momen A; Al-Diab A; Abdulkarim H; Alameri H
    Saudi Med J; 2007 Jul; 28(7):1072-5. PubMed ID: 17603714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iron overload in sickle cell anemia : a study of 94 patients].
    Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
    Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients.
    Arduini A; Bonomini M; Clutterbuck EJ; Laffan MA; Pusey CD
    Nephrol Dial Transplant; 2006 Sep; 21(9):2671-2. PubMed ID: 16611680
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
    J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle-cell anemia and pulmonary hypertension.
    Ninkovich GM; Miller SK; Alpert PT
    J Am Acad Nurse Pract; 2010 Apr; 22(4):198-204. PubMed ID: 20409257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Debate forum: carnitine supplements have not been demonstrated as effective in patients on long-term dialysis therapy.
    Handelman GJ
    Blood Purif; 2006; 24(1):140-2. PubMed ID: 16361854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.
    Ambrusko SJ; Gunawardena S; Sakara A; Windsor B; Lanford L; Michelson P; Krishnamurti L
    Pediatr Blood Cancer; 2006 Dec; 47(7):907-13. PubMed ID: 16496290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial.
    Wang WC; Morales KH; Scher CD; Styles L; Olivieri N; Adams R; Brambilla D;
    J Pediatr; 2005 Aug; 147(2):244-7. PubMed ID: 16126058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure in acute vaso-occlusive crises of sickle cell disease.
    Ernst AA; Weiss SJ; Johnson WD; Takakuwa KM
    South Med J; 2000 Jun; 93(6):590-2. PubMed ID: 10881775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension of sickle cell disease: more than just another lung disease.
    Klings ES
    Am J Hematol; 2008 Jan; 83(1):4-5. PubMed ID: 17924550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study.
    Koshy M; Burd L; Wallace D; Moawad A; Baron J
    N Engl J Med; 1988 Dec; 319(22):1447-52. PubMed ID: 3054555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
    Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP
    Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary complications of sickle cell disease.
    Khoury RA; Musallam KM; Mroueh S; Abboud MR
    Hemoglobin; 2011; 35(5-6):625-35. PubMed ID: 21973051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.
    Castro O; Gladwin MT
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):881-96, vii. PubMed ID: 16214649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.